The role of ubiquitin-proteasome system in glioma survival and growth

References

• Adams J. 2003. The proteasome: Structure, function, and role in the cell. Cancer Treat Rev 29:3–9
   PubMed Web of Science ®Google Scholar
• Alberts GF, Winkles JA. 2004. Murine FGF-inducible kinase is rapidly degraded via the nuclear ubiquitin-proteosome system when overexpressed in NIH 3T3 cells. Cell Cycle 3:678–684
   PubMed Web of Science ®Google Scholar
• Arora S, Yang JM, Hait WN. 2005. Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase. Cancer Res 65:3806–3810
   PubMedGoogle Scholar
• Baron V, Schwartz M. 2000. Cell adhesion regulates ubiquitin-mediated degradation of the platelet-derived growth factor receptor beta. J Biol Chem 275:39318–39323
   PubMed Web of Science ®Google Scholar
• Beinke S, Ley SC. 2004. Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem J 382:393–409
   PubMed Web of Science ®Google Scholar
• Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25:917–931
   PubMed Web of Science ®Google Scholar
• Brown RE, Law A. 2006. Morphoproteomic demonstration of constitutive nuclear factor-κB activation in glioblastoma multiforme with genomic correlates and therapeutic implications. Ann Clin Lab Sci 36:421–426
   PubMed Web of Science ®Google Scholar
• Burger AM, Seth AK. 2004. The ubiquitin-mediated protein degradation pathway in cancer: Therapeutic implications. Eur J Cancer 40:2217–2229
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068
   PubMed Web of Science ®Google Scholar
• Chapman G, Liu L, Sahlgren C, Dahlqvist C, Lendahl U. 2006. High levels of Notch signaling down-regulate Numb and Numblike. J Cell Biol 175:535–540
   PubMed Web of Science ®Google Scholar
• Chitra S, Nalini G, Rajasekhar G. 2012. The ubiquitin proteasome system and efficacy of proteasome inhibitors in diseases. Int J Rheum Dis 15:249–260
   PubMed Web of Science ®Google Scholar
• Chondrogianni N, Gonos ES. 2012. Structure and function of the ubiquitin-proteasome system: Modulation of components. Prog Mol Biol Transl Sci 109:41–74
   PubMed Web of Science ®Google Scholar
• Chuang JY, Wang YT, Yeh SH, Liu YW, Chang WC, Hung JJ. 2008. Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol Biol Cell 19:1139–1151
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Orian A, Schwartz AL. 2000. Ubiquitin-mediated proteolysis: Biological regulation via destruction. Bioessays 22:442–451
   PubMed Web of Science ®Google Scholar
• Dahmane N, Sánchez P, Gitton Y, Palma V, Sun T, Beyna M, Weiner H, Ruiz i Altaba A. 2001. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 128:5201–5212
   PubMed Web of Science ®Google Scholar
• Dai B, Pieper RO, Li D, Wei P, Liu M, Woo SY, Aldape KD, et al. 2010. FoxM1B regulates NEDD4-1 expression, leading to cellular transformation and full malignant phenotype in immortalized human astrocytes. Cancer Res 70:2951–2961
   PubMed Web of Science ®Google Scholar
• Dai S, Huang ML, Hsu CY, Chao KS. 2003. Inhibition of hypoxia inducible factor 1alpha causes oxygen-independent cytotoxicity and induces p53 independent apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys 55:1027–1036
   PubMed Web of Science ®Google Scholar
• Di K, Linskey ME, Bota DA. 2012. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth. Oncogene doi: 10.1038/onc.2012.531. [Epub ahead of print]
   Google Scholar
• Di Marcotullio L, Ferretti E, Greco A, De Smaele E, Po A, Sico MA, Alimandi M, et al. 2006. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol 8:1415–1423
   PubMed Web of Science ®Google Scholar
• Eichhorn PJ, Rodón L, Gonzàlez-Juncà A, Dirac A, Gili M, Martínez-Sáez E, Aura C, et al. 2012. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma. Nat Med 18:429–435
   PubMed Web of Science ®Google Scholar
• Froment P, Dupont J, Christophe-Marine J. 2008. Mdm2 exerts pro-apoptotic activities by antagonizing insulin-like growth factor-I-mediated survival. Cell Cycle 7:3098–3103
   PubMed Web of Science ®Google Scholar
• Gillespie DL, Whang K, Ragel BT, Flynn JR, Kelly DA, Jensen RL. 2007. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 13:2441–2448
   PubMed Web of Science ®Google Scholar
• Glasgow E, Mishra L. 2008. Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer 15:59–72
   PubMed Web of Science ®Google Scholar
• Glogowska A, Stetefeld J, Weber E, Ghavami S, Hoang-Vu C, Klonisch T. 2012. Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells. Neoplasia 14:396–409
   PubMed Web of Science ®Google Scholar
• Goswami S, Gupta A, Sharma SK. 1998. Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG. J Neurochem 71:1837–1845
   PubMed Web of Science ®Google Scholar
• Gur G, Rubin C, Katz M, Amit I, Citri A, Nilsson J, Amariglio N, et al. 2004. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J 23:3270–3281
   PubMed Web of Science ®Google Scholar
• Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G, Fukushima T. 2001. Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas. Neurol Med Chir (Tokyo) 41:187–195
   PubMed Web of Science ®Google Scholar
• He S, Deng J, Li G, Wang B, Cao Y, Tu Y. 2012. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma. Jpn J Clin Oncol 42:196–201
   PubMed Web of Science ®Google Scholar
• Heldin CH, ten Dijke P. 1999. SMAD destruction turns off signalling. Nat Cell Biol 1:E195–197
   PubMed Web of Science ®Google Scholar
• Herrmann J, Ciechanover A, Lerman LO, Lerman A. 2004. The ubiquitin-proteasome system in cardiovascular diseases -- A hypothesis extended. Cardiovasc Res 61:11–21
   PubMed Web of Science ®Google Scholar
• Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. 1999. NF-κB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 19:2690–2698
   PubMed Web of Science ®Google Scholar
• Hoeller D, Hecker CM, Dikic I. 2006. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 6:776–788
   PubMed Web of Science ®Google Scholar
• Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. 2003. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 115:565–576
   PubMed Web of Science ®Google Scholar
• Izaguirre DI, Zhu W, Hai T, Cheung HC, Krahe R, Cote GJ. 2012. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis. Mol Carcinog 51:895–906
   PubMed Web of Science ®Google Scholar
• Janssens S, Tschopp J. 2006. Signals from within: The DNA-damage-induced NF-κB response. Cell Death Differ 13:773–784
   PubMed Web of Science ®Google Scholar
• Jiang W, Cazacu S, Xiang C, Zenklusen JC, Fine HA, Berens M, Armstrong B, et al. 2008. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-κB signaling pathway. Neoplasia 10:235–243
   PubMed Web of Science ®Google Scholar
• Jiang X, Xing H, Kim TM, Jung Y, Huang W, Yang HW, Song S, et al. 2012. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and skp1-cullin-f-box ubiquitin ligase activity. Stem Cells 30:1313–1326
   PubMed Web of Science ®Google Scholar
• Joy A, Moffett J, Neary K, Mordechai E, Stachowiak EK, Coons S, Rankin-Shapiro J, et al. 1997. Nuclear accumulation of FGF-2 is associated with proliferation of human astrocytes and glioma cells. Oncogene 14:171–183
   PubMed Web of Science ®Google Scholar
• Kermorgant S, Zicha D, Parker PJ. 2003. Protein kinase C controls microtubule-based traffic but not proteasomal degradation of c-Met. J Biol Chem 278:28921–28929
   PubMed Web of Science ®Google Scholar
• Kim K, Brush JM, Watson PA, Cacalano NA, Iwamoto KS, McBride WH. 2008. Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation. Mol Cancer Res 6:426–434
   PubMed Web of Science ®Google Scholar
• Korkolopoulou P, Levidou G, Saetta AA, El-Habr E, Eftichiadis C, Demenagas P, Thymara I, et al. 2008. Expression of nuclear factor-kappaB in human astrocytomas: Relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol 39:1143–1152
   PubMed Web of Science ®Google Scholar
• Krakauer T. 2008. Nuclear factor-kappaB: Fine-tuning a central integrator of diverse biologic stimuli. Int Rev Immunol 27:286–292
   PubMed Web of Science ®Google Scholar
• Lennartsson J, Wardega P, Engström U, Hellman U, Heldin CH. 2006. Alix facilitates the interaction between c-Cbl and platelet-derived growth factor beta-receptor and thereby modulates receptor down-regulation. J Biol Chem 281:39152–39158
   PubMed Web of Science ®Google Scholar
• Li X, Liu J, Gao T. 2009a. β-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt. Mol Cell Biol 29:6192–6205
   PubMed Web of Science ®Google Scholar
• Li JJ, Liu DP, Liu GT, Xie D. 2009b. EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor. Oncogene 28:1759–1768
   PubMed Web of Science ®Google Scholar
• Li G, Xu Y, Guan D, Liu Z, Liu DX. 2011. HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation. J Biol Chem 286:20251–20259
   PubMedGoogle Scholar
• Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, Aldape KD, et al. 2006. FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66:3593–3602
   PubMed Web of Science ®Google Scholar
• Magnani M, Crinelli R, Bianchi M, Antonelli A. 2000. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-κB (NF-κB). Curr Drug Targets 1:387–399
   PubMedGoogle Scholar
• Mani A, Gelmann EP. 2005. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol 23:4776–4789
   PubMed Web of Science ®Google Scholar
• Mao H, Lebrun DG, Yang J, Zhu VF, Li M. 2012. Deregulated signaling pathways in glioblastoma multiforme: Molecular mechanisms and therapeutic targets. Cancer Invest 30:48–56
   PubMed Web of Science ®Google Scholar
• McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, et al. 2009. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell 16:44–54
   PubMedGoogle Scholar
• Monnier L, Milano G, Penault-Llorca F, Merlin JL. 2004. Targeting of membrane receptor tyrosine kinases: Is there resistance in the HER? [Article in French] Bull Cancer 91:685–694
   PubMed Web of Science ®Google Scholar
• Nagai S, Washiyama K, Kurimoto M, Takaku A, Endo S, Kumanishi T. 2002. Aberrant nuclear factor-κB activity and its participation in the growth of human malignant astrocytoma. J Neurosurg 96:909–917
   PubMed Web of Science ®Google Scholar
• Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HJ. 1998. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 95:5724–5729
   PubMed Web of Science ®Google Scholar
• Otsuka G, Nagaya T, Saito K, Mizuno M, Yoshida J, Seo H. 1999. Inhibition of nuclear factor-κB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Cancer Res 59:4446–4452
   PubMed Web of Science ®Google Scholar
• Oved S, Mosesson Y, Zwang Y, Santonico E, Shtiegman K, Marmor MD, Kochupurakkal BS, et al. 2006. Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases. J Biol Chem 281:21640–21651
   PubMed Web of Science ®Google Scholar
• Platten M, Wick W, Weller M. 2001. Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401–410
   PubMed Web of Science ®Google Scholar
• Preusser M, Haberler C, Hainfellner JA. 2006. Malignant glioma: Neuropathology and neurobiology. Wien Med Wochenschr 156:332–337
   PubMedGoogle Scholar
• Ruano Y, Mollejo M, Camacho FI, Rodríguez de Lope A, Fiaño C, Ribalta T, Martínez P, et al. 2008. Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme. Cancer 112:1575–1584
   PubMed Web of Science ®Google Scholar
• Rubtsov YP, Rudensky AY. 2007. TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7:443–453
   PubMed Web of Science ®Google Scholar
• Ruiz i Altaba A, Mas C, Stecca B. 2007. The Gli code: An information nexus regulating cell fate, stemness and cancer. Trends Cell Biol 17:438–447
   PubMed Web of Science ®Google Scholar
• Ruiz i Altaba A, Palma V, Dahmane N. 2002. Hedgehog-Gli signalling and the growth of the brain. Nat Rev Neurosci 3:24–33
   PubMed Web of Science ®Google Scholar
• Sallinen SL, Sallinen PK, Kononen JT, Syrjäkoski KM, Nupponen NN, Rantala IS, Helén PT, et al. 1999. Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis. J Pathol 188:289–293
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Li Y, Wang Z, Kong D. 2008. NF-κB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 27:293–319
   PubMed Web of Science ®Google Scholar
• Schmidt MH, Dikic I. 2006. Ubiquitin and NEDD8: Brothers in arms. Sci STKE 2006:pe50
   PubMedGoogle Scholar
• Schmidt MH, Furnari FB, Cavenee WK, Bögler O. 2003. Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization. Proc Natl Acad Sci USA 100:6505–6510
   PubMed Web of Science ®Google Scholar
• Seton-Rogers S. 2009. Tumour suppressors: Different roads to inactivation. Nat Rev Cancer 9:610
   PubMed Web of Science ®Google Scholar
• Smith D, Shimamura T, Barbera S, Bejcek BE. 2008. NF-κB controls growth of glioblastomas/astrocytomas. Mol Cell Biochem 307:141–147
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS, Pieper RO. 2001. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 61:4956–4960
   PubMed Web of Science ®Google Scholar
• Stachowiak EK, Maher PA, Tucholski J, Mordechai E, Joy A, Moffett J, Coons S, Stachowiak MK. 1997. Nuclear accumulation of fibroblast growth factor receptors in human glial cells – Association with cell proliferation. Oncogene 14:2201–2211
   PubMed Web of Science ®Google Scholar
• Stecca B, Ruiz i Altaba A. 2009. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 28:663–676
   PubMed Web of Science ®Google Scholar
• Stutz MA, Shattuck DL, Laederich MB, Carraway KL 3rd, Sweeney C. 2008. LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII. Oncogene 27:5741–5752
   PubMed Web of Science ®Google Scholar
• Sugawa N, Ekstrand AJ, James CD, Collins VP. 1990. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87:8602–8606
   PubMed Web of Science ®Google Scholar
• Thaker NG, Zhang F, McDonald PR, Shun TY, Lewen MD, Pollack IF, Lazo JS. 2009. Identification of survival genes in human glioblastoma cells by small interfering RNA screening. Mol Pharmacol 76:1246–1255
   Google Scholar
• Thomas CY, Chouinard M, Cox M, Parsons S, Stallings-Mann M, Garcia R, Jove R, Wharen R. 2003. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int J Cancer 104:19–27
   PubMed Web of Science ®Google Scholar
• Thompson SJ, Loftus LT, Ashley MD, Meller R. 2008. Ubiquitin-proteasome system as a modulator of cell fate. Curr Opin Pharmacol 8:90–95
   PubMed Web of Science ®Google Scholar
• Trojan J, Cloix JF, Ardourel MY, Chatel M, Anthony DD. 2007. Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 145:795–811
   PubMed Web of Science ®Google Scholar
• Uehara T, Matsuno J, Kaneko M, Nishiya T, Fujimuro M, Yokosawa H, Nomura Y. 1999. Transient nuclear factor κB (NF-κB) activation stimulated by interleukin-1beta may be partly dependent on proteasome activity, but not phosphorylation and ubiquitination of the IkappaBalpha molecule, in C6 glioma cells. Regulation of NF-κB linked to chemokine production. J Biol Chem 274:15875–15882
   Google Scholar
• Walter KA, Hossain MA, Luddy C, Goel N, Reznik TE, Laterra J. 2002. Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription. Mol Cell Biol 22:2703–2715
   PubMed Web of Science ®Google Scholar
• Warfel NA, Niederst M, Stevens MW, Brennan PM, Frame MC, Newton AC. 2011. Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt. J Biol Chem 286:19777–19788
   PubMed Web of Science ®Google Scholar
• Wen PY, Kesari S. 2008. Malignant gliomas in adults. N Engl J Med 359:492–507
   PubMed Web of Science ®Google Scholar
• Westermark B, Heldin CH, Nistér M. 1995. Platelet-derived growth factor in human glioma. Glia 15:257–263
   PubMed Web of Science ®Google Scholar
• Wu TF, Zhang W, Su ZP, Chen SS, Chen GL, Wei YX, Sun T, et al. 2012. UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro. Asian Pac J Cancer Prev 13:5137–5142
   PubMedGoogle Scholar
• Xu T, Zhou Q, Zhou J, Huang Y, Yan Y, Li W, Wang C, et al. 2011. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci 102:959–966
   Google Scholar
• Yamamoto M, Fukushima T, Hayashi S, Ikeda K, Tsugu H, Kimura H, Soma G, Tomonaga M. 2000. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Anticancer Res 20:611–618
   PubMed Web of Science ®Google Scholar
• Yang W, Wang L, Roehn G, Pearlstein RD, Ali-Osman F, Pan H, Goldbrunner R, et al. 2013. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival. Cancer Sci 104:70–77
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang C, Li L, Gao Y, Luo X, Zhang Y, Liu W, Fei Z. 2012. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma. World J Surg Oncol 10:169
   PubMed Web of Science ®Google Scholar
• Yeo CW, Ng FS, Chai C, Tan JM, Koh GR, Chong YK, Koh LW, et al. 2012. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival. Cancer Res 72:2543–2553
   PubMed Web of Science ®Google Scholar
• Yokouchi M, Kondo T, Houghton A, Bartkiewicz M, Horne WC, Zhang H, Yoshimura A, Baron R. 1999. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J Biol Chem 274:31707–31712
   PubMed Web of Science ®Google Scholar
• Yuan J, Tu Y, Mao X, He S, Wang L, Fu G, Zong J, Zhang Y. 2012. Increased expression of FAT10 is correlated with progression and prognosis of human glioma. Pathol Oncol Res 18:833–839
   PubMed Web of Science ®Google Scholar
• Yue S, Chen Y, Cheng SY. 2009. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway. Oncogene 28:492–499
   PubMed Web of Science ®Google Scholar
• Zerbini LF, Wang Y, Czibere A, Correa RG, Cho JY, Ijiri K, Wei W, et al. 2004. NF-κ B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci USA 101:13618–13623
   PubMed Web of Science ®Google Scholar
• Zhang F, Laiho M. 2003. On and off: Proteasome and TGF-beta signaling. Exp Cell Res 291:275–281
   PubMed Web of Science ®Google Scholar
• Zhang P, Lathia JD, Flavahan WA, Rich JN, Mattson MP. 2009. Squelching glioblastoma stem cells by targeting REST for proteasomal degradation. Trends Neurosci 32:559–565
   PubMed Web of Science ®Google Scholar
• Zhao Z, Tan X, Zhao A, Zhu L, Yin B, Yuan J, Qiang B, Peng X. 2012. microRNA-214-mediated UBC9 expression in glioma. BMB Rep 45:641–646
   PubMed Web of Science ®Google Scholar
• Zhou YX, Chen SS, Wu TF, Ding DD, Chen XH, Chen JM, Su ZP, et al. 2012. A novel gene RNF138 expressed in human gliomas and its function in the glioma cell line U251. Anal Cell Pathol (Amst) 35:167–178
   PubMedGoogle Scholar
• Zuo W, Huang F, Chiang YJ, Li M, Du J, Ding Y, Zhang T, et al. 2013. c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. Mol Cell 49:499–510
   PubMed Web of Science ®Google Scholar